Temsirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

Summary

This phase II trial is studying how well temsirolimus works in treating patients with relapsed or refractory multiple myeloma. Drugs used in chemotherapy such as temsirolimus work in different ways to stop cancer cells from dividing so they stop growing or die.

Timeline

Start

2004-02

Primary completion

2007-02

Completion

—

Drugs

Indications